Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
THE ROAD AHEAD Our commitment to responsible business practices COMMITTED TO OUR RESPONSIBILITY In Ireland and around the world, AbbVie is committed to having a remarkable impact on people’s lives. A simple statement perhaps, but think about what that means: to have a truly remarkable impact means that we must strive to be remarkable in all we do. We do this by listening to changing patient needs, looking and thinking ahead, and constantly innovating. By innovating our product offerings, educating our patients, supporting our healthcare professionals and increasing access to care, this remarkable impact is happening right now, all around us. Our remarkable impact is not limited to our customers. We pledge to be a responsible corporate citizen, mindful of our responsibilities to our people, our communities and our environment. AbbVie Ireland has developed a vision of responsible business. We are developing an ethical business culture, a sustainable supply chain and a responsible approach to research. We are working with our employees to engage them with this vision. We are advancing responsible research and believe in delivering exemplary ecological stewardship. AbbVie Ireland is committed to communicating openly and clearly with you, our stakeholders. This commitment begins with this booklet, which sets out the road ahead towards sustained responsible business practice. This booklet signals our intent to live up to our responsibilities to our people, our communities and our environment in an open, transparent and consistent way. We will introduce you to our new company and its strong heritage. We will demonstrate the unwavering focus we have on helping the patients who rely on us to reach their highest potential. We will introduce you to AbbVie in Ireland, demonstrating our commitment to the country and its people. And we will outline how we will make a real difference through our approach to corporate social responsibility here in Ireland, and how we will measure and share our performance through our annual report card. Young Social Innovators is a youth organisation that believes in the power of young people to bring about change in their communities. It focuses on empowering young people through education for social innovation. AbbVie embarked on a pioneering programme with the charity to run a series of EXPLORE Social Innovation Workshops in Dublin, Sligo and Cork schools. These workshops are tailored to ignite the creativity of 15 to 18 year olds and empower them to recognise their potential to make a positive difference to their lives, the lives of others and to wider society. THE ROAD AHEAD: OUR COMMITMENT TO RESPONSIBLE BUSINESS PRACTICE COMMITTED TO OUR RESPONSIBILITY1 ABOUT ABBVIE HU MA RE SO N UR CE S CO INV MM OL UNI VE ME TY NT PATIENTS IAL RC ME ONS M CO RATI E OP VA L UE CH AIN BORATI ON LLA CO AbbVie has an absolute commitment to the patient. We draw on our deep expertise in some of the most difficultto-treat diseases to deliver hope to those in need. We seek to understand all aspects of a patient’s journey with their illness so that we are better equipped to find solutions. This patient-centred approach to discovery and development helps ensure we remain focused on the task of improving lives as we seek to make the most positive impact possible on the health of society. H& RC NT E SEA RE OPM L VE E D CE PATIENT-CENTRED TER AF NAL FAI RS AN AbbVie produces a range of products and we have many more in development. These are targeted at complex and difficult-to-treat areas. In Ireland, our company markets treatments for advanced Parkinson’s disease and a medicine to prevent respiratory infections that can have very serious consequences for the health of premature and vulnerable infants. Other AbbVie products licensed here help those with a wide range of immunemediated conditions including rheumatoid arthritis, Crohn’s disease, ulcerative colitis, and psoriasis. EX FIN AbbVie was founded in 2013 when Abbott, a proven healthcare leader with a 125-year heritage of achievement, was separated into two publicly listed companies. The outcome was a new organisation called AbbVie that retained the expertise and world-wide reach of a proven industry achiever, but also displayed the focus, passion and innovation of a newly-established enterprise. Y EG AT AbbVie’s nurse-led service allows treatment of premature infants to take place in the home setting Research and innovation are the cornerstones of AbbVie’s business as a global biopharmaceutical company. Our work in this area focuses on developing medicines that deliver strong clinical performance, provide more patient benefit and offer economic value, particularly where there is significant need in certain disease areas. STR THE HISTORY OF A NEW BEGINNING RESEARCH AND INNOVATION OVATION INN AbbVie is a global, research-based biopharmaceutical company. Our 25,000 people – including more than 400 based in Ireland – move science forward by applying a unique approach to innovation, developing advanced medicines and marketing our products in more than 170 countries. Aiming to have a remarkable impact on patients, we take on today’s most complex and challenging diseases. We use collaboration and innovation to put patients at the centre of everything we do. One of AbbVie’s medicines is administered to vulnerable infants to help protect them from Respiratory Syncytial Virus or RSV, a leading cause of bronchiolitis and pneumonia during the winter months. Synacare is a service provided by AbbVie which involves a qualified paediatric nurse travelling to the family home and administering the preventative treatment each month during the RSV season. This means these young patients are kept away from crowded waiting rooms where they are at risk of contracting RSV and other winter infections. Since it started in 2008, over 4,000 infants and their families have benefited from the service which has removed more than 18,500 appointments from the hospital system. 2 THE ROAD AHEAD: OUR COMMITMENT TO RESPONSIBLE BUSINESS PRACTICE ABOUT ABBVIE3 ABBVIE IN IRELAND ABBVIE CORK ABBVIE SLIGO AbbVie Ireland operates two separate plants in Sligo employing more than 200 staff. The company’s high containment facility on the Manorhamilton Road was established in 2002 and has dedicated capabilities for potent active pharmaceutical ingredient and drug product manufacturing. AbbVie Sligo Manorhamilton Road The quality control labs are equipped with the latest design technology for chemical and microbiological analytical testing to meet customers’ needs. This site recently underwent a significant €85 million expansion that doubled its footprint and provided additional capability to support AbbVie’s new product introductions. AbbVie has a second manufacturing site in Sligo at Ballytivnan. Founded in 1974, this plant is now a global centre of excellence for design control and precision engineering in the production of drug delivery devices. AbbVie Dublin Liffey Valley ABBVIE DUBLIN The company’s commercial offices are located at the Liffey Valley Office Campus in Quarryvale, west Dublin. More than 70 people work here overseeing the sale, supply, distribution and marketing of the company’s Irish-licensed products. AbbVie’s Medical Director and Irish support team work from this site. AbbVie Sligo Ballytivnan A second office at Woodford Business Park, Santry, north Dublin is an international base for a range of AbbVie manufacturing and engineering services. These support company plants all around the world. The office is a key base for senior management, finance, engineering, quality assurance (QA), programme management, projects and packaging, engineering, environmental health services, talent acquisition, purchasing and development processes. Among the products made at this location are components for a pen-style device used by patients who have been prescribed a company treatment for rheumatoid arthritis, Crohn’s disease, psoriasis and other immune mediated inflammatory conditions. The treatment can be delivered via a syringe or our pen device but 70% of patients surveyed preferred this latter option, showing how we use patients’ needs to drive our innovation. 4 Our plant in Carrigtwohill, on the outskirts of Cork, is a modern ‘bulk tablet’ finish facility which manufactures solid and capsule formulations. Innovative new technologies, in combination with the depth of expertise that exists within the local workforce, allow those based there to develop and deliver products and processes to support AbbVie’s wider global needs. These range from small scale clinical trial supply to large commercial manufacturing. AbbVie Cork Carrigtwohill THE ROAD AHEAD: OUR COMMITMENT TO RESPONSIBLE BUSINESS PRACTICE AbbVie Dublin Santry ABBVIE IN IRELAND5 OUR CORPORATE SOCIAL RESPONSIBILITY FRAMEWORK FOUR UNIQUE OPPORTUNITIES TIED TO OUR FRAMEWORK FOR CHANGE AbbVie’s corporate responsibility framework has been structured to allow us to deliver on four unique opportunities: our environment, our community, our workplace and our marketplace. We are committed to supporting patients as they make their journey through the continuum of care in order to improve health outcomes. We utilise the potential of advanced science by leveraging the expertise of our people to address global health needs, improve outcomes and raise standards, all while building health system capacity and increasing access to care. And we are committed to maintaining our role as a global philanthropic leader4 dedicated to transforming education and narrowing the achievement gap in science and literacy. ENVIRONMENT Optimally managing the world’s limited resources is a key business responsibility and AbbVie understands that efficient environmental strategies are crucial to ensure this. 6 THE ROAD AHEAD: OUR COMMITMENT TO RESPONSIBLE BUSINESS PRACTICE COMMUNITY We recognise that building trust and reputation in our communities is also essential to the long-term sustainability of our business. WORKPLACE In the workplace, AbbVie is committed to building the capability of our employees by developing their skills to help them reach their full potential. MARKETPLACE AbbVie is committed to ethical business practices in the marketplace and we strive to meet the highest levels of professional standards. OUR CORPORATE SOCIAL RESPONSIBILITY FRAMEWORK7 SOME EXAMPLES OF WHAT WE’VE ACHIEVED TO DATE ENVIRONMENT AbbVie Ireland in Sligo achieved a 14% reduction in CO2 emissions over the period 2010-2012 versus a target of 12%. The Manorhamilton Road plant installed a low pressure hot water energy (LPHW) building heating system that will reduce the site’s CO2 emissions by 572 tonnes and deliver significant annual savings. This energy project won an AbbVie Global Environmental Health and Safety award for 2013. A new AbbVie solution for GPs struggling to find time to attend educational meetings is also delivering an environmental benefit. Dr Robert Coughlan, a Galwaybased consultant rheumatologist, has organised a continuing series of highly-successful online seminars for GPs. The online seminar saved approximately 445,220km of travel, equating to approximately 31,801 litres of fuel. AbbVie also sends all certificates of attendance (860 pages to date) and training materials (4,300 pages so far) electronically via email to each attendee, saving trees and contributing to a greener environment. All three AbbVie manufacturing sites hold an ISO 14001 Environment Management Services Certificate whilst Cork has been awarded an ISO 50001, an international standard for energy management which provides a robust framework for optimising energy efficiency. 8 COMMUNITY AbbVie encourages its workforce to actively support worthy community causes and Irish-based employees volunteered over 1,700 hours last year in partnerships with charities, hospitals and schools. AbbVie and its employees made donations and raised funds for a range of causes last year including the new Cardiology Ward at Our Lady’s Hospital for Sick Children in Crumlin, the Irish Cancer Society, the Irish Blood Transfusion Service and the North West Hospice. AbbVie has partnered with Young Social Innovators to enable this highly respected charity run a series of school workshops across the country. These speciallydesigned events encourage teenagers to consider harnessing their unique creative potential by playing an active role in addressing societal issues that affect them and their peers. The work of Young Social Innovators has played a leading role in demonstrating how Irish students can deliver vital change on a wide range of issues from cyber bullying and health awareness to animal welfare and social inclusion. AbbVie volunteers have assisted in delivering workshops at almost twenty schools in Sligo, Dublin and Cork. THE ROAD AHEAD: OUR COMMITMENT TO RESPONSIBLE BUSINESS PRACTICE WORKPLACE Our company is committed to creating opportunities to innovate, collaborate and demonstrate excellence every day. We offer numerous career paths to help our people succeed in our many businesses and functions, including research and development, technology, finance, operations, regulatory affairs and compliance, medical affairs, sales, marketing, human resources and more. Last year across AbbVie’s sites in Ireland this commitment to developing our people was brought to life with 15% of our employees moving to the next level in their career through a promotion. The key defining feature of a great workplace is the level of trust that exists within it. For employees, a great workplace is one where you trust the people you work with, you have great pride in what you do, and you enjoy the people you work with. The Great Place to Work Institute assesses the policies and practices in place in organisations. It then benchmarks these against other organisations in each country. The Institute conducts an anonymous ‘Trust Index Survey’ that gathers the employees’ views. Finally, there is an in-depth qualitative analysis of open ended comments from employees. AbbVie entered this competition for the first time in 2014 and the judges selected it among the Top 20 Best Large Workplaces in Ireland.2 MARKETPLACE Our AbbVie Code of Business Conduct, published in print and online in 32 different languages, sets out core guidance and requirements in this regard. Our employees read and certify this code annually. AbbVie expects its business partners, including contract workers, vendors, suppliers and consultants, to adhere to ethical behaviour within the spirit of this code, and to also observe all applicable laws and regulations when working on our behalf. When it comes to innovation, AbbVie starts with the patients. This often involves delivering value beyond the medicine. One of the ways we do this is by assisting patient organisations such as Move4Parkinson’s, a remarkable charity which harnesses the power of singing to life-changing effect. Mags Mullarney of Move4Parkinson’s said, “AbbVie has made resources available…which support people with Parkinson’s and helps them to have a better quality of life. However, perhaps even more important has been the support that AbbVie and its employees have offered members of Move4Parkinsons and their families at a human level in terms of genuine interest, care, respect and understanding. We believe AbbVie truly understands the meaning of patient engagement.” SOME EXAMPLES OF WHAT WE’VE ACHIEVED TO DATE9 GLOBAL ABBVIE EXAMPLES OF OUR CORPORATE RESPONSIBILITY APPROACH AbbVie aims to have a remarkable impact on patients’ lives at a local and global level. We try to achieve this as a sustainable business, as a responsible corporate citizen, and as a philanthropic leader. Corporate responsibility efforts are focused on our unique opportunities to support patients, build capacity, leverage expertise and transform education. SUPPORT PATIENTS In 2013, more than 100 of AbbVie’s most experienced scientists contributed their expertise to helping solve NTDs through drug development projects, advisory boards and compound screening partner organizations. AbbVie has provided over 100,000 of our compounds for screening against diseases like tuberculosis. TRANSFORM EDUCATION As a new company, we’re just beginning our journey to impact education. We’re focusing on narrowing the achievement gap in science and literacy. We’re making a difference in education in our local communities – and around the world. AbbVie is proud of our long-term partnership with the Asian University for Women based in Bangladesh that aims to educate a new generation of leaders in Asia. AbbVie scientists provide weekly lectures via video conference to 25 senior level science students at the university. We support the patient journey through the continuum of care to improve health outcomes. Innovative patient programmes meet patients’ needs around the world. The AbbVie Foundation’s Global AIDS Care Programme has reached more than six million children and families, donated more than 24 million HIV rapid tests and invested more than $275 million to combat AIDS in the developing word. BUILD CAPACITY AbbVie partners and collaborates with others to build health system capacity and infrastructure in order to increase access to care. AbbVie and the AbbVie Foundation provided more than $1.5 million in critically-needed product donations and $550,000 in cash grants to respond to disasters in 2013. We partner with leading organisations, such as the Baylor College of Medicine Pediatric AIDS Initiative, which we’ve supported to build paediatric HIV clinics first in Romania and then replicated in Malawi and Tanzania. LEVERAGE EXPERTISE AbbVie aims to leverage our expertise and resources to address global health needs and improve standards of care. AbbVie is committed to addressing and solving 10 In 2014, the AbbVie Foundation will launch a new science education programme delivered by AbbVie employees globally. Ireland is the first country to launch this new programme in primary schools in Dublin, Cork and Sligo. The AbbVie Foundation’s long-term partnership with AMPATH in Kenya currently helps support the care and treatment of 160,000 HIV patients. This is part of the AbbVie Global AIDS Care program that has reached more than six million patients in the past ten years. the world’s recognised health challenges, including Neglected Tropical Diseases (NTDs). NTDs are a group of infections that disproportionately impact the world’s poor and marginalised populations. According to the World Health Organisation, more than one billion people suffer from one or more of these conditions. THE ROAD AHEAD: OUR COMMITMENT TO RESPONSIBLE BUSINESS PRACTICE RESPONSIBLE BUSINESS FOCUS GLOBALLY Ethical culture: Our interactions with healthcare professionals are meant to impact patient care and are guided by openness and transparency. Responsible research: We engage in responsible research practices that respect patients. Engaged employees: In 2014, AbbVie is launching a new program called ‘Possibilities 365’ to facilitate employees’ volunteering and giving efforts globally. Ireland is a global pilot for this new programme due to employees’ commitment to their communities. Healthy environment: AbbVie aims for 20% reduction in carbon as CO2e total water intake and total waste disposal by 2020 (normalized by sales and over a 2013 baseline). In addition, we aim to reduce AbbVie’s recordable incidents 20% by 2020 (absolute number). Sustainable supply chain: In 2013, AbbVie’s first annual Supplier Sustainability Survey found 23% of key suppliers to be sustainable. Our goal is to work with key suppliers so that 50% are designated sustainable in 2014, and 100% by 2017. Strategic philanthropy: AbbVie and AbbVie’s foundations’ 2013 grants and charitable donations were more than $905 million. Since the pursuit of possibility takes root at a young age, AbbVie supports the Kohl Children’s Museum’s travelling science laboratory exhibit to encourage an interest in science among students. More than 9,500 children and families visited the exhibit when it was on display in Brazil in 2013. AbbVie employees also volunteered at the exhibit to conduct activities for children, sharing their love of science with the young visitors. GLOBAL ABBVIE EXAMPLES OF OUR CORPORATE RESPONSIBILITY APPROACH11 MEASURING UP TO OUR COMMITMENTS AbbVie is a new company and although we have only just begun our corporate responsibility journey, we have already managed a number of notable achievements. We’ve received a prestigious Western Europe Region Corporate Energy Management Award1 from the Association of Energy Engineers. We have entered a partnership with the charity Young Social Innovators to encourage young adults to play their vital role in helping to improve our society3. And we have been voted one of Ireland’s best places to work. But there is much yet to do… COMMUNICATIONS AND GOVERNANCE As a new company steeped in a century-long tradition of responsibility, AbbVie is committed to improving lives and we pledge to go about it in a transparent way. We plan to replicate the openness and accountability that is a hallmark of our company’s financial reporting in the way we communicate our corporate social responsibility activity in Ireland. Good communication goes hand-in-hand with good governance and we intend to make a documented commitment to assessing responsible business practices across all aspects of our business. We will do this by undertaking and publishing an annual responsible business audit. This document will report on and measure our performance as a company in this sphere of activity. 12 THE ROAD AHEAD: OUR COMMITMENT TO RESPONSIBLE BUSINESS PRACTICE THE ABBVIE REPORT CARD In 2015, the AbbVie Report Card will establish the company’s performance across a range of responsible business priorities. Each year we will assess how we measured up to our commitments and set new goals for improving our results. The AbbVie Responsible Business Report Card will help us to: Measure our environmental impact in areas such as energy use, water intake, waste disposal and recycling and set environmentally sustainable targets across all Irish sites Define, explain and demonstrate our commitment to the local communities in which we work Facilitate analysis and improvement of workplace standards ranging from personal and career development opportunities to delivering accident-free working environments Ensure the company does all it can to promote responsible business behaviours in the marketplace, including maintaining continuity of supply and improving supplier standards The AbbVie Report Card will provide us with an opportunity to define our company’s approach to responsible business with our stakeholders in a transparent manner. We will circulate it to our people and to wider society. In this way, we will ensure that our responsible business performance is measured against a series of publicly defined priorities at a local, national and international level. MEASURING UP TO OUR COMMITMENTS13 ENVIRONMENT COMMUNITY WORKPLACE MARKETPLACE For further information on the company and its people, portfolio and commitments, please contact: Robert Love (Head of Communications) AbbVie Limited Block B, Liffey Valley Office Campus, Quarryvale, Co. Dublin Telephone: 01 428 7900 Email: [email protected] References: 1. Association of Energy Engineers (AEE) Western Europe Region Corporate Energy Management Award, 2012. 2. AbbVie came 16th in the Great Places to Work Ireland rankings in 2013. 3. AbbVie ‘Schools Innovation Workshop’ partnership with YSI, 2013. Date of Preparation: August 2014 | IRECOR140171 This booklet is printed on 100% recycled paper